Published by Coherent Market Insights
Posted on October 1, 2021
5 min readLast updated: February 1, 2026
The Hemodialysis Access Graft market is expanding due to rising renal disorders and strategic mergers. North America leads with high CKD prevalence.
Hemodialysis vascular grafts are advanced medical device that is widely used to treat the renal disorder. This device effectively remove and return blood during hemodialysis and provide good blood flow for dialysis. Hemodialysis vascular grafts devices are manufactured by using different materials such as polyurethane, polyester, polytetrafluoroethylene, and biological materials.
The increasing prevalence of renal disorder is predominantly augmenting the market growth of hemodialysis vascular grafts. Moreover, the increasing geriatric population around the globe is again raising the prevalence of chronic disease such as chronic kidney disease which is further augmenting the market growth. Furthermore, growing investment in the field of vascular access graft is again contributing to market growth. Additionally, increasing number strategic merger and acquisition is further projected to accelerate the market growth. For instance, in June 2020, LeMaitre Vascular, Inc. announced that it has acquired the business and assets of Artegraft, Inc. for $90.0 million. Under the terms of the deal, LeMaitre will continue to operate Artegraft’s manufacturing facility processes and sells biologic vascular grafts derived from bovine carotid arteries and are implanted primarily in hemodialysis access patients.
Request Sample Copy of This Report @
https://www.coherentmarketinsights.com/insight/request-sample/1840
Major Players in Hemodialysis Access Graft Market
W.L. Gore & Associated, C. R. Bard, Merit Medical Systems, Inc. and Getinge Group.
North America is expected to gain significant growth over the forecast period and this is attributed to increasing utilization of biological and tissue-engineered vascular access grafts coupled with the high prevalence of CDK in the region. According to the National Kidney Foundation Inc., chronic kidney disease affects an estimated 37 million people in the U.S. and around 90% of those with CKD don’t even know they have it. 1 in 3 American adults (around 80 million people) is at risk for CKD. In 2017, over 500,000 patients received dialysis treatment, and over 200,000 lived with a kidney transplant.
Key Developments:
In September 2019, Healionics Corporation has announced that it has raised a fund of $4.5 million to help a trial on its new vascular access device.
In November 2017, Vascular Flow Technologies enter into a partnership with Biovic. The goal of this partnership is to enhance Biovic’s existing AVATAR(R) ePTFE Vascular Graft by using VFT’s Spiral Laminar Flow (SLF(TM)) technology
In December 2019, CryoLife, Inc. announced it has received European CE Mark approval for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections.
In June 2018, Fresenius Medical Care, the provider of dialysis products and services, and Humacyte, Inc., announced a strategic, global partnership and a $150M USD equity investment. This agreement has the potential to make Humacyte’s investigational human acellular vessel, HUMACYL®
Ask for PDF sample copy of the Hemodialysis Access Graft market report @
https://www.coherentmarketinsights.com/insight/request-pdf/1840
Why this is Important Report to you? It helps:
• To analyze and study the Global Hemodialysis Access Graft Market capacity, production, value, consumption, status Focuses on the Key Hemodialysis Access Graft manufacturers, to study the capacity, production, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application, and region.
• To analyze the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
• To identify significant trends and factors driving or inhibiting market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the Hemodialysis Access Graft Market.
• To strategically profile the key players and comprehensively analyze their growth strategies.
• It provides a forward-looking perspective on different factors driving or restraining Market growth.
• It provides a six-year forecast assessed on the basis of how the Market is predicted to grow.
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors.
• It helps in making informed business decisions by having complete insights and by making an in-depth analysis of Market segment
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/1840
In conclusion, the Hemodialysis Access Graft market report presents the descriptive analysis of the parent market supported elite players, present, past, and artistic movement information which is in a position to function as a profitable guide for all the Hemodialysis Access Graft industry business competitors. Our expert research analyst’s team has been trained to supply in-depth marketing research reports from every individual sector which can be helpful to know the industry data within the most precise way.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
The post Hemodialysis Access Graft Market Is Booming Worldwide and Comprehensive Study 2021-2028 | W.L. Gore & Associated, C. R. Bard, Merit Medical Systems appeared first on Gatorledger.
The article discusses the growth and factors driving the Hemodialysis Access Graft market from 2021 to 2028.
The market is growing due to the increasing prevalence of renal disorders and strategic investments.
Major players include W.L. Gore, C.R. Bard, and Merit Medical Systems.
Explore more articles in the Research Reports category
